Choudhry Swati, Balzer David, Murphy Joshua, Nicolas Ramzi, Shahanavaz Shabana
Division of Pediatric Cardiology, Department of Pediatrics, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri.
Catheter Cardiovasc Interv. 2016 Mar;87(4):757-61. doi: 10.1002/ccd.26310. Epub 2015 Dec 23.
Carotid artery access in infants with congenital heart disease undergoing cardiac catheterization via a surgical cut down has been well described. There is a paucity of information regarding percutaneous carotid artery (CA) access in infants <3 months.
A retrospective review of infants <3 months of age undergoing cardiac catheterization via percutaneous CA approach was performed after IRB approval. Between January 2012 and May 2015, 18 patients underwent 20 procedures; median age 13 days (2-77); median weight 3.3 kg (1.6-5). Procedures performed were patent ductus arteriosus (PDA) stenting (8), modified blalock taussig (BT) shunt stenting (3), balloon aortic valvuloplasty (6), and balloon angioplasty of coarctation (3).
Percutaneous access was obtained with a Doppler needle under ultrasound guidance into the right (16) and left CA (4). Sheath size used was 4 Fr (17), 5 Fr (2), and 6 Fr (1). Median time to sheath insertion was 6.5 min (2-20). Percutaneous access was obtained successfully in all cases. There were no major procedural complications. There were two minor complications; hypotension, and ductal spasm. Hemostasis was achieved by manual compression; median time was 14.5 min (8-36). There were two post-procedural complications involving development of CA pseudo aneurysms that were repaired surgically. Post-procedure CA patency was documented by angiography (3), MRA (3), or vascular ultrasound (14). There were no documented arterial occlusions.
Our experience suggests that percutaneous CA access in infants <3 months of age is safe and feasible with preserved vascular patency and no neurological adverse events.
对于患有先天性心脏病且需通过手术切开进行心导管插入术的婴儿,颈动脉入路已有详尽描述。关于3个月以下婴儿经皮颈动脉(CA)入路的信息较少。
在获得机构审查委员会(IRB)批准后,对3个月以下经皮CA入路进行心导管插入术的婴儿进行回顾性研究。2012年1月至2015年5月期间,18例患者接受了20次手术;中位年龄13天(2 - 77天);中位体重3.3千克(1.6 - 5千克)。所进行的手术包括动脉导管未闭(PDA)支架置入术(8例)、改良布莱洛克 - 陶西格(BT)分流支架置入术(3例)、球囊主动脉瓣成形术(6例)以及主动脉缩窄球囊血管成形术(3例)。
在超声引导下使用多普勒针经皮进入右侧CA(16例)和左侧CA(4例)。所使用的鞘管尺寸为4F(17例)、5F(2例)和6F(1例)。鞘管插入的中位时间为6.5分钟(2 - 20分钟)。所有病例均成功获得经皮入路。无重大手术并发症。有2例轻微并发症;低血压和导管痉挛。通过手动压迫实现止血;中位时间为14.5分钟(8 - 36分钟)。有2例术后并发症涉及CA假性动脉瘤形成,通过手术修复。术后通过血管造影(3例)、磁共振血管造影(MRA,3例)或血管超声(14例)记录CA通畅情况。无动脉闭塞记录。
我们的经验表明,3个月以下婴儿经皮CA入路是安全可行的,可保持血管通畅且无神经学不良事件。